We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J, Janssen Win Mass. Risperdal Suit On Teen's Weight Gain

Law360 (September 5, 2018, 5:26 PM EDT) -- Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. on Wednesday prevailed over claims in Massachusetts federal court saying their antipsychotic drug Risperdal caused a Bay State man to gain excessive...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Subscribers Only

Date Filed

November 30, 2015

Law Firms

Companies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.